Literature DB >> 110187

Pulmonary alveolar proteinosis: analysis of airway and alveolar proteins.

D Y Bell, G E Hook.   

Abstract

Lavage effluents from the lungs of patients with pulmonary alveolar proteinosis were analyzed for soluble constitutents. Antiserums monospecific for normal plasma components, C-reactive protein, and secretory piece were used to investigate the presence of these proteins in lavage effluent, wheras 2-dimensional polyacrylamide gel electrophoresis provided a comprehensive map of the major proteins that were present. The proteins of lung washing obtained from normal subjects and of patient and normal serums were similarly analyzed. Most of the soluble-phase proteins from lavage of patients with pulmonary alveolar proteinosis were also found in patient serum, and were present in amounts consistent with a theory that they originate from the plasma by passage through channels of approximately normal size and selectivity. This findings suggests that the abundant soluble protein found in the alveoli of the lungs of these patients does not arise by leakage through a serverly damaged blood-air barrier. Patients had in their lung lavage effluents 2 soluble proteins of molecular weights 47,000 and 52,000 daltons not found in their serum and not present in lung washings from normal subjects. Uniformly increased concentrations of immunoglobulins in patient lavage effluent, abnormal immunoglobulin concentrations in patient serum, and the presence of C-reactive protein in the serum from 4 of 5 patients indicate a response of the immune system to the disease process and suggest that an atypical hypersensitivity reaction may be involved.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110187     DOI: 10.1164/arrd.1979.119.6.979

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury.

Authors:  Lynn M Schnapp; Samuel Donohoe; Jinzhi Chen; Donald A Sunde; Patricia M Kelly; John Ruzinski; Thomas Martin; David R Goodlett
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 3.  Shotgun MS proteomic analysis of bronchoalveolar lavage fluid in normal subjects.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Lynn M Schnapp; David R Goodlett
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

Review 4.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

5.  Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years.

Authors:  K Kariman; J A Kylstra; A Spock
Journal:  Lung       Date:  1984       Impact factor: 2.584

6.  Bronchoalveolar lavage.

Authors:  J B Gee; R B Fick
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

7.  A macrophage-suppressing 40-kD protein in a case of pulmonary alveolar proteinosis.

Authors:  J Müller-Quernheim; R E Schopf; P Benes; V Schulz; R Ferlinz
Journal:  Klin Wochenschr       Date:  1987-10-01

8.  Isolation and possible relevance of Thermoactinomyces candidus proteinases in farmer's lung disease.

Authors:  R C Roberts; L P Nelles; M W Treuhaft; J J Marx
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

Review 9.  The pulmonary extracellular lining.

Authors:  G George; G E Hook
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

Review 10.  Biochemical and cellular mechanisms of dust-induced lung fibrosis.

Authors:  R J Richards; C G Curtis
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.